February 2017 Briefing – Pathology
Here are what the editors at HealthDay consider to be the most important developments in Pathology for February 2017. This roundup includes the latest...
Exposure to Neuraminidase Inhibitors in Utero Not Harmful
No increased risks of adverse neonatal outcomes or congenital malformations with in utero exposure
Review Supports Link Between Adiposity, Risk of Some Cancers
Excess weight may influence risk of GI cancers by altering insulin levels, promoting inflammation
Colorectal Cancer Rates, Mortality Down in Americans Aged ≥50
Report suggests higher screening rates explain the positive trend
Comorbid Neuropathies Common With MCI Diagnosis
Mixed Alzheimer's disease neuropathic changes more frequent than pure ADNC among those with MCI
Biomarker in Nasal Passages May ID Lung Cancer in Smokers
Simple technique is based on cancer DNA and seems accurate for use after chest CT scan, researchers say
Strategies Suggested to Protect Practices From Hackers
Small practices are a target, especially as larger organizations improve their security
CRC Incidence on the Rise Among Younger Americans
Rates of rectal cancer have been rising longer and faster than colon cancer
Physician Burnout Eroding Sense of Calling
Physicians who are completely burned out have lower odds of six validated aspects of sense of calling
ACOG Recommends Use of Carrier Screening Before Pregnancy
Two Committee Opinions expand guidelines on carrier screening; highlight importance of counseling
